• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edwards Lifesciences (NY: EW )

    66.69 +0.22 (+0.33%)
    Official Closing Price Updated: 7:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Edwards Lifesciences

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    EW INVESTORS: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Edwards Lifesciences Corporation Class Action
    From Robbins LLP
    Via GlobeNewswire
    EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    TOP RANKED ROSEN LAW FIRM Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Cracking The Code: Understanding Analyst Reviews For Edwards Lifesciences
    Via Benzinga
    Unpacking the Latest Options Trading Trends in Edwards Lifesciences
    Via Benzinga
    DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Edwards Lifesciences Corporation to Contact Us to Have Their Losses Evaluated Today
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
    From The Rosen Law Firm PA
    Via GlobeNewswire
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
    From Edwards Lifesciences Corporation
    Via Business Wire
    Why is Boston Scientific Stock Trading Lower On Wednesday?
    Boston Scientific's ACURATE IDE trial results showed a 16.16% composite rate for mortality, stroke, or rehospitalization, not meeting non-inferiority versus controls. 
    Via Benzinga
    TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
    From Edwards Lifesciences Corporation
    Via Business Wire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TD, Edwards, and UPS and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
    From Edwards Lifesciences Corporation
    Via Business Wire
    EW CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) and Lead Plaintiff Deadline on December 13, 2024
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    EW CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) and Lead Plaintiff Deadline on December 13, 2024
    NEW YORK - (NewMediaWire) - October 28, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or the... 
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Edwards Lifesciences Corporation Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
    Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks. 
    Via Benzinga
    Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
    The major indexes were mixed for the week. 
    Via Investor's Business Daily
    EDWARDS LIFESCIENCES DEADLINE FOR LEADERSHIP is December 13, 2024 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    Exposures Financial Legal
    EDWARDS LIFESCIENCES DEADLINE FOR LEADERSHIP is December 13, 2024 in a Securities Fraud Lawsuit - Contact Kaplan Fox &amp; Kilsheimer LLP
    NEW YORK, NY - (NewMediaWire) - October 25, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or... 
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Exposures Financial Legal
    AutoNation, Capital One Financial And 3 Stocks To Watch Heading Into Friday
    Via Benzinga
    Edwards Lifesciences Pops After Wrapping A Key Divestiture And Beating Profit Views
    The company also reiterated its outlook for sales to grow 8% to 10% this year. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Edwards Lifesciences Reports Third Quarter Results
    From Edwards Lifesciences Corporation
    Via Business Wire
    After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
    EW Investors with Losses Encouraged to Contact the Firm 
    From Hagens Berman Sobol Shapiro LLP
    Via GlobeNewswire
    Tech Stocks Rebound, Tesla Soars To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
    Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
    Via Benzinga
    EW DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before December 13, 2024
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    EW DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before December 13, 2024
    NEW YORK, NY - (NewMediaWire) - October 24, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or... 
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    Tech Stocks Rebound With Tesla Soaring To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
    Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.